Sesame Street marketing executive moves to St. Jude

Can you tell me how to get to Sesame Street? The new chief marketing officer for St. Jude Children's Research Hospital's fundraising wing knows how to get there. 

Samantha Maltin, the former marketing lead at Sesame Workshop—the nonprofit behind the long-running PBS show—has joined ALSAC, to help raise awareness of St. Jude’s research initiatives and fundraising drives. 

In a statement, St. Jude said Maltin brings “25 years of experience as a brand leader, largely in the entertainment and media space,” with notable credits at the History Channel and Nickelodeon. 

Now, she will bring her skills in marketing and promotion to healthcare.

“From the first moment I visited the St. Jude campus, I felt a deep connection to the mission of supporting the world’s most vulnerable children and families. Sharing their stories, inspiring compassion, and rallying support to make a lasting difference—that’s exactly where I want to dedicate my energy and my heart,” Maltin said in the statement. “I’m thrilled to work alongside the ALSAC team to further advance the impact of the lifesaving work of St. Jude and continue building hope for so many.”

During her tenure at Sesame Street, Maltin oversaw consumer engagement and strategic communications, including branding, social media, and event planning. She took on the role in 2019 and left in October for her new position at St. Jude.

Maltin plans to relocate to Memphis, Tennessee, where the main St. Jude campus is located. 

It’s unclear if characters such as Big Bird and Ernie will make their way into future St. Jude outreach efforts, but it wouldn’t be without precedent. The television show’s characters have been known to make appearances alongside various brands and charities.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Trimed Popup
Trimed Popup